REPORT ID 2859

China Asthma Treatment Drugs Market Research Report 2017

Publish Date
11-Dec-17
Pages
99
Format
Electronic (PDF)

The global Asthma Treatment Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Asthma Treatment Drugs development status and future trend in China, focuses on top players in China, also splits Asthma Treatment Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    GlaxoSmithKline
    Sanofi
    Roche & Novartis
    Teva
    Merck
    AstraZeneca
    Boehringer Ingelheim
    ...

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
    Long-term Control Medications
    Quick-relief Medications (Rescue Medications)
    Medications for Allergy-induced Asthma

On the basis of the end users/application, this report covers
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Asthma Treatment Drugs Market Research Report 2017
1 Asthma Treatment Drugs Overview
    1.1 Product Overview and Scope of Asthma Treatment Drugs
    1.2 Classification of Asthma Treatment Drugs by Product Category
        1.2.1 China Asthma Treatment Drugs Sales (K Pcs) Comparison by Type (2012-2022)
        1.2.2 China Asthma Treatment Drugs Sales (K Pcs) Market Share by Type in 2016
        1.2.3 Long-term Control Medications
        1.2.4 Quick-relief Medications (Rescue Medications)
        1.2.5 Medications for Allergy-induced Asthma
    1.3 China Asthma Treatment Drugs Market by Application/End Users
        1.3.1 China Asthma Treatment Drugs Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 China Asthma Treatment Drugs Market by Region
        1.4.1 China Asthma Treatment Drugs Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Asthma Treatment Drugs Status and Prospect (2012-2022)
        1.4.3 East China Asthma Treatment Drugs Status and Prospect (2012-2022)
        1.4.4 Southwest China Asthma Treatment Drugs Status and Prospect (2012-2022)
        1.4.5 Northeast China Asthma Treatment Drugs Status and Prospect (2012-2022)
        1.4.6 North China Asthma Treatment Drugs Status and Prospect (2012-2022)
        1.4.7 Central China Asthma Treatment Drugs Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Asthma Treatment Drugs (2012-2022)
        1.5.1 China Asthma Treatment Drugs Sales (K Pcs) and Growth Rate (%)(2012-2022)
        1.5.2 China Asthma Treatment Drugs Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Asthma Treatment Drugs Market Competition by Players/Manufacturers
    2.1 China Asthma Treatment Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Asthma Treatment Drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Asthma Treatment Drugs Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
    2.4 China Asthma Treatment Drugs Market Competitive Situation and Trends
        2.4.1 China Asthma Treatment Drugs Market Concentration Rate
        2.4.2 China Asthma Treatment Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Asthma Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 China Asthma Treatment Drugs Sales and Revenue by Region (2012-2017)
    3.1 China Asthma Treatment Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
    3.2 China Asthma Treatment Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Asthma Treatment Drugs Price (USD/Pcs) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Asthma Treatment Drugs Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Asthma Treatment Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Asthma Treatment Drugs Price (USD/Pcs) by Type (2012-2017)
    4.4 China Asthma Treatment Drugs Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Asthma Treatment Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
    5.2 China Asthma Treatment Drugs Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Asthma Treatment Drugs Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Roche & Novartis
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Roche & Novartis Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Teva
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Merck
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Boehringer Ingelheim
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Asthma Treatment Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Boehringer Ingelheim Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Asthma Treatment Drugs Manufacturing Cost Analysis
    7.1 Asthma Treatment Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Asthma Treatment Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Asthma Treatment Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Asthma Treatment Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Asthma Treatment Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Asthma Treatment Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Asthma Treatment Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    11.3 China Asthma Treatment Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 China Asthma Treatment Drugs Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List